B
Ben Thornley
Researcher at University of Leeds
Publications - 8
Citations - 530
Ben Thornley is an academic researcher from University of Leeds. The author has contributed to research in topics: Placebo & Number needed to treat. The author has an hindex of 4, co-authored 8 publications receiving 516 citations. Previous affiliations of Ben Thornley include Cochrane Collaboration.
Papers
More filters
Journal ArticleDOI
Content and quality of 2000 controlled trials in schizophrenia over 50 years.
Ben Thornley,Clive E Adams +1 more
TL;DR: The drug regulatory authorities should stipulate that the results of both explanatory and pragmatic trials are necessary before a compound is given a licence for everyday use, and much scope for well planned, conducted, and reported trials is left.
Journal ArticleDOI
Chlorpromazine versus placebo for schizophrenia
TL;DR: It is found chlorpromazine provided a global improvement in a person's symptoms and functioning and reduces relapse over the short and medium term and in the long term.
Journal ArticleDOI
Chlorpromazine for schizophrenia: a Cochrane systematic review of 50 years of randomised controlled trials
Clive E Adams,John Rathbone,Ben Thornley,Mike Clarke,Jo Borrill,Kristian Wahlbeck,A. George Awad +6 more
TL;DR: It is understandable why the World Health Organization have endorsed and included chlorpromazine in their list of essential drugs for use in schizophrenia, and low- and middle-income countries may have more complete evidence upon which to base their practice compared with richer nations using recent innovations.